• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi , March 15

JANSSEN Pharmaceutica of Belgium is planning to increase its presence in India by forging alliances for marketing as well as manufacturing of pharmaceutical products.

Speaking to newspersons, Dr Ajit Shetty, Chairman and Managing Director, Janssen, said, "We are investigating our opportunities in India and will invest accordingly." He was not willing to put a figure to the investments. However, he said the company is looking at partnerships in the area of research and development, discovery, clinical research and chemical manufacturing.

Currently, the company has a presence in India through Janssen-Cilag Pharmaceuticals, part of Johnson & Johnson (J&J) Ltd. Internationally, too, Janssen is part of the J&J group of companies.

Janssen is planning to make India a global resource centre. "We have a small research and development (R&D) facility in Mumbai with 22 people, which we plan to increase for servicing our international projects," said Mr Hasit Joshipura, President and Executive Director of the Indian operations. It is also planning to focus on the biotech segment in a big way.

Mr Shetty said that with the patents regime in place, India could become an attractive destination for launching new products. "Our products have been copied in India and the Indian versions are very successful. With the new IPR regime, we hope to be bringing in new products," he said. Janssen had products for various therapeutic segments, including fungal infections, allergies, mental health, neurology and cancer.

Meanwhile, Janssen has signed a memorandum of understanding with the Archaeological Survey of India towards maintenance, conservation and preservation of protected monuments of Hampi Temple Complex and Tipu Sultan's Palace in Karnataka. The two parties will conduct research on the treatment of bio-deterioration of cultural heritage monuments.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Madhucon bags Kalwakurti project

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line